Synapse - JAK2/PD-L1/PD-L2 (9p24.1) amplified renal cell carcinoma: Implications for clinical management

JAK2/PD-L1/PD-L2 (9p24.1) amplified renal cell carcinoma: Implications for clinical management Meeting Abstract

Authors:	Gupta, S.; Cheville, J.; Jungbluth, A.; Zhang, Y.; Zhang, L.; Chen, Y. B.; Tickoo, S.; Fine, S.; Gopalan, A.; Al-Ahmadie, H.; Sirintrapun, S. J.; Blum, K.; Lohse, C.; Hakimi, A.; Thompson, R. H.; Leibovich, B.; Berger, M.; Arcila, M.; Ross, D.; Ladanyi, M.; Antonescu, C.; Reuter, V.
Abstract Title:	JAK2/PD-L1/PD-L2 (9p24.1) amplified renal cell carcinoma: Implications for clinical management
Meeting Title:	108th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP)
Journal Title:	Modern Pathology
Volume:	32
Issue:	Suppl. 2
Meeting Dates:	2019 Mar 16-21
Meeting Location:	National Harbor, MD
ISSN:	0893-3952
Publisher:	Nature Research
Date Published:	2019-03-01
Start Page:	63
End Page:	64
Language:	English
ACCESSION:	WOS:000478915502278
PROVIDER:	wos
PUBMED:	30886285
DOI:	10.1038/s41379-019-0237-5
Notes:	Meeting Abstract: 855 -- Source: Wos